RDY 311 (Nizatidine 300 mg)
Pill imprint RDY 311 has been identified as Nizatidine 300 mg.
Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer prophylaxis; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 311
- Strength:
- 300 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0311
- Inactive Ingredients:
- croscarmellose sodium
povidone
corn starch
dimethicone
magnesium silicate
titanium dioxide
gelatin
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferric oxide black
Note: Inactive ingredients may vary.
More about nizatidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: H2 antagonists
Consumer resources
Other brands: Axid, Axid AR, Axid Pulvules
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
